2010
DOI: 10.1074/jbc.m110.126664
|View full text |Cite
|
Sign up to set email alerts
|

Specific Inhibition of NEIL-initiated Repair of Oxidized Base Damage in Human Genome by Copper and Iron

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
54
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
7
3

Relationship

3
7

Authors

Journals

citations
Cited by 66 publications
(55 citation statements)
references
References 79 publications
1
54
0
Order By: Relevance
“…1D). Hegde et al reported that NEIL1 initiates repair of oxidized base damage is specifically inhibited by copper and iron (Hegde, Hegde et al 2010). Based on this, we initially hypothesized that the AD brains might have elevated iron deposition that may inhibit NEIL1 activity without loss of protein quantity.…”
Section: Discussionmentioning
confidence: 99%
“…1D). Hegde et al reported that NEIL1 initiates repair of oxidized base damage is specifically inhibited by copper and iron (Hegde, Hegde et al 2010). Based on this, we initially hypothesized that the AD brains might have elevated iron deposition that may inhibit NEIL1 activity without loss of protein quantity.…”
Section: Discussionmentioning
confidence: 99%
“…General reduction in DNA repair capacity during ageing and in sporadic NDDs could involve multiple mechanisms including, (i) altered transcriptional regulation causing reduced expression of a repair protein (e.g., reduced levels of MRN, DNA-PKcs [143, 163] in CS; reduced OGG1 (in mitochondria) [164] and Polβ in AD [165], reduced breast cancer associated gene 1 (BRCA1) in AD brain [166]); (ii) inhibition of catalytic activity of repair proteins, whose levels are otherwise comparable to healthy neurons in the CNS, primarily by NDD-linked etiological factors like exposure to excessive pro-oxidant metals and ROS (e.g., metal and ROS-mediated inhibition of NEIL1, NEIL2, LigIII, APE1 etc., in AD and PD [167, 168]; reduced catalytic activity of OGG1 in AD [136, 169] and reduced Polβ activity in AD [136, 165] and (iii) abnormal degradation and/or mis-localization of repair proteins (e.g., degradation of ATM and PARP1 by caspases/Matrix-Metallo-Proteinases (MMPs) [170], nuclear to cytoplasmic mis-localization of FUS in ALS [13]. Most of the NDDs have complex etiologies including oxidative stress, pro-oxidant metal and other toxic free radicals, and the misfolded/aggregating protein response, together with extensive accumulation of various types of DNA damages [18].…”
Section: Dna Repair Defects and Neuronal Phenotypesmentioning
confidence: 99%
“…Based on the relative success of synthetic lethality of PARP inhibitors with drug/radiation treatment of BRCA-negative breast cancer [174], BER/SSBR inhibitors could also provide effective alternative synthetic lethality strategy. In particular, DNA glycosylases, which we showed to regulate and control the complete repair sub-pathways [68,175,31] and/or DNA ligase III/DNA ligase I, the two key nick-sealing enzymes [176,177] have strong potential as synthetic lethality targets which is currently being explored by our and others’ laboratories.…”
Section: Ber/ssbr An Attractive Anti-cancer Target In Synthetic Lethmentioning
confidence: 99%